LAMA2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: The diagnostic rate achieved in this study was very high with a potentially disease-causing mutation detected in 86% (6/7) of individuals in Group I (suspected dystroglycanopathy) and 100% (5/5) in Group II (suspected merosin-deficient CMD).